MERAIODE: A Phase II Redifferentiation Trial with Trametinib and 131I in Metastatic Radioactive Iodine Refractory RAS Mutated Differentiated Thyroid Cancer

Thyroid ®, Ahead of Print.

Source: Thyroid - July 26, 2023 Category: Endocrinology Authors: Sophie Leboulleux Daniele Benisvy David Taieb Marie Attard Claire Bournaud Marie Terroir-Cassou-Mounat Ludovic Lacroix Nadege Anizan Aurelie Schiazza Marie Eve Garcia Abir Al Ghuzlan Livia Lamartina Martin Schlumberger Yann Godbert Isabelle Borget Source Type: research